Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation

Fig. 2

Eriodictyol ameliorates cognitive deficits in APP/PS1 mice determined using Y-maze tests. A Percentage of alternations and B total entries during 8 min were recorded in spontaneous alternation tests and novel arm exploration tests. C The percentage of novel arm entries. D The time spent in the novel arm and E the total entries within 5 min were recorded. F The track of mice in the Y-maze during spontaneous alternation tests and novel arm exploration tests. Data are presented as means ± SD, n = 6. **P < 0.01 and ***P < 0.001 compared with the APP/PS1-control group

Back to article page

Molecular Medicine

ISSN: 1528-3658